Person:
Wright, Diane Lynne

Profile Picture

Email Address

AA Acceptance Date

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Wright

First Name

Diane Lynne

Name

Wright, Diane Lynne

Filters

20121

Settings

Author's Publications: search.filters.isAuthorOfPublication.ce8a9887-b418-412b-b4ca-11d7dca43f6b

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    Publication
    Urinary Bisphenol A Concentrations and Implantation Failure among Women Undergoing in Vitro Fertilization
    (National Institute of Environmental Health Sciences, 2012) Ehrlich, Shelley; Williams, Paige; Missmer, Stacey; Flaws, Jodi A.; Berry, Katharine F.; Calafat, Antonia M.; Ye, Xiaoyun; Petrozza, John; Wright, Diane Lynne; Hauser, Russ
    Background: Bisphenol A (BPA) is a synthetic chemical widely used in the production of polycarbonate plastic and epoxy resins found in numerous consumer products. In experimental animals, BPA increases embryo implantation failure and reduces litter size. Objective: We evaluated the association of urinary BPA concentrations with implantation failure among women undergoing in vitro fertilization (IVF). Methods: We used online solid phase extraction–high performance liquid chromatography–isotope dilution tandem mass spectrometry to measure urinary BPA concentrations in 137 women in a prospective cohort study among women undergoing IVF at the Massachusetts General Hospital Fertility Center in Boston, Massachusetts. We used logistic regression to evaluate the association of cycle-specific urinary BPA concentrations with implantation failure, accounting for correlation among multiple IVF cycles in the same woman using generalized estimating equations. Implantation failure was defined as a negative serum β-human chorionic gonadotropin test (β-hCG < 6 IU/L) 17 days after egg retrieval. Results: Among 137 women undergoing 180 IVF cycles, urinary BPA concentrations had a geometric mean (SD) of 1.53 (2.22) µg/L. Overall, 42% (n = 75) of the IVF cycles resulted in implantation failure. In adjusted models, there was an increased odds of implantation failure with higher quartiles of urinary BPA concentrations {odds ratio (OR) 1.02 [95% confidence interval (CI): 0.35, 2.95}, 1.60 (95% CI: 0.70, 3.78), and 2.11 (95% CI: 0.84, 5.31) for quartiles 2, 3, and 4, respectively, compared with the lowest quartile (p-trend = 0.06). Conclusion: There was a positive linear dose–response association between BPA urinary concentrations and implantation failure.